Physician profile
Ryan Hubbard
NPI 1184030009
$25,373.43
in general payments reported to CMS, 2019-2025
17 companies · $5,011 in 2025
The $5,011 reported for 2025 was more than what 98% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $268 · 2021: $236 · 2022: $2,108 · 2023: $7,006 · 2024: $535 · 2025: $5,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,700 · Food and Beverage: $4,389 · Travel and Lodging: $2,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,699.89 |
| Food and Beverage | $4,389.03 |
| Travel and Lodging | $2,462.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2019 | |
| Sonex Health, INC. | $6,581.13 | 2020-2025 | Sx-One Microknife |
| Trice Medical, INC. | $3,397.76 | 2022-2023 | |
| Medtronic, INC. | $2,390.93 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Pacira Pharmaceuticals Incorporated | $2,171.47 | 2023-2025 | Iovera, Zilretta, Exparel |
| Avanos Medical | $143.98 | 2023 | Coolief* Cooled Radiofrequency |
| Fidia Pharma USA INC. | $141.27 | 2023-2025 | Hymovis, Triluron |
| Bioventus LLC | $132.73 | 2020-2025 | Durolane, Xcell |
| Medical Device Business Services, INC. | $105.15 | 2019 | |
| Djo, LLC | $104.97 | 2019 | |
| Tenex Health INC. | $78.85 | 2020 | |
| Depuy Synthes Sales INC. | $34.71 | 2021 | |
| Amgen INC. | $24.89 | 2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $20.61 | 2025 | |
| Acumed LLC | $18.74 | 2025 | Acumed |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.97 | 2022 | |
| Theragen, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.